Zusammenfassung
Eine 30-jährige schwangere Patientin mit Typ-1-Diabetes seit der Kindheit, einer Albuminurie, einem systolischen Blutdruck von 150 mm Hg vor Schwangerschaft, jetzt Spitzen bis zu 170 mm Hg und einem HbA1c von 7,3 %. Welche Medikamente sind sinnvoll?
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Abalos E, Duley L, Steyn DW, Henderson-Smart DJ (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 1:CD002252
Bortolus R, Ricci E, Chatenoud L, Parazzini F (2000) Nifedipine administered in pregnancy: effect on the development of children at 18 months. BJOG 107(6):792–794. https://doi.org/10.1111/j.1471-0528.2000.tb13342
Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116(2 Pt 1):402–414. https://doi.org/10.1097/AOG.0b013e3181e9322a
Cooper W, Hernandez-Diaz S, Arbogast P, Dudley J, Dyer S, Gideon P, Hall K, Ray W (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451
Hiilesmaa V, Suhonen L, Teramo K (2000) Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 43(12):1534–1539. https://doi.org/10.1007/s001250051565
Houtzager BA, Hogendoorn SM, Papatsonis DN, Samsom JF, van Geijn HP, Bleker OP, van Wassenaer AG (2006) Long-term follow up of children exposed in utero to nifedipine or ritodrine for the management of preterm labour. BJOG 113(3):324–331
Magee L, von Dadelszen P et al (2015) Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. N Engl J Med 372:407–417. https://doi.org/10.1056/NEJMoa1404595
Montan S, Anandakumar C, Arulkumaran S et al (1993) Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 168(1):152–156. https://doi.org/org/10.1016/S0002-9378(12)90905-9
Nielsen LR, Müller C, Damm P, Mathiesen ER (2006) Reduced prevalence of early preterm delivery in women with Type 1 diabetes and microalbuminuria − Possible effect of early antihypertensive treatment during pregnancy. Diabet Med 23(4):426–431
Nielsen LR, Damm P, Mathiesen E (2009) Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy, effect of intensified antihypertensive therapy? Diabetes Care 32(1):38–44. https://doi.org/10.2337/dc08-1526
Regitz-Zagrosek V, Gohlke-Bärwolf C, Haass M, Nienaber C, RybakK Seeland U (2011) “ESC Guidelines on the management of cardiovascular diseases during pregnancy“ European Society of Cardiology. Eur Heart J 32:3147–3197. https://doi.org/10.1093/eurheartj/ehr218
Rüster C, Hasslacher C, Wolf G (2016) Diabetische Nephropathie, Leitlinien Deutsch Diabetes Gesellschaft. Diabetologie 11(S02):S93–S98. https://doi.org/10.1055/s-0042-113138
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Valkanou, A. (2018). Fall 22: Schwangerschaft – 30 Jahre, ♀, schwanger, DM Typ 1, Blutdruckspitzen. In: Kihm, L., Kopf, S., Nawroth, P. (eds) Diabetes-Therapie – informiert entscheiden. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55972-7_22
Download citation
DOI: https://doi.org/10.1007/978-3-662-55972-7_22
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-55971-0
Online ISBN: 978-3-662-55972-7
eBook Packages: Medicine (German Language)